Skip to main content

Advertisement

Log in

Coronary microvascular function in patients with Cushing’s syndrome

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

The aim of the study was to evaluate patients with Cushing’s syndrome the coronary flow reserve (CFR), an index of coronary microvascular function. Fifteen newly diagnosed patients with Cushing’s syndrome (1 male/14 females; mean age 45 ± 11 years), were selected for having no clinical evidence of ischemic heart disease. Twelve patients had pituitary-dependent Cushing’s disease and three had an adrenal adenoma. Fifteen subjects matched for age, sex, and major cardiovascular risk factors were used as controls. Coronary flow velocity in the left anterior descending coronary artery was investigated by transthoracic Doppler echocardiography at rest and during adenosine infusion. CFR was obtained as the ratio hyperemic/resting diastolic flow velocity. A reduced coronary reserve (hyperemic/resting ratio ≤2.5) was found in 5/15 Cushing patients and 4/15 controls. In all patients with abnormal CFR, epicardial coronary stenosis was excluded by multi-slice computed tomographic coronary angiography. CFR was inversely related to urinary cortisol in patients with endogenous hypercortisolism (Spearman’s rho = −0.57, P = 0.03), while no correlation was found in controls. Coronary microvascular function, as assessed by CFR, is pathologically reduced in a considerable number of patients with Cushing’s syndrome without clinical symptoms of ischemic heart disease and in the absence of epicardial coronary artery lesions, as well as in controls matched for cardiovascular risk factors. The presence of comorbidities can explain this early coronary abnormality in both patients and controls. Whether urinary cortisol may be a predictor of coronary microvascular function in the setting of patients with Cushing’s syndrome, needs further investigation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. M. Boscaro, L. Barzon, F. Fallo, N. Sonino, Cushing’s syndrome. Lancet 357, 783–791 (2001)

    Article  PubMed  CAS  Google Scholar 

  2. G. Arnaldi, A. Angeli, A.B. Atkinson, X. Bertagna, F. Cavagnini, G.P. Chrousos, G.A. Fava, J.W. Findling, R.C. Gaillard, A.B. Grossman, B. Kola, A. Lacroix, T. Mancini, F. Mantero, J. Newell-Price, L.K. Nieman, N. Sonino, M.L. Vance, A. Giustina, M. Boscaro, Diagnosis and complications of Cushing’s syndrome: a consensus statement. J. Clin. Endocrinol. Metab. 88, 5593–5602 (2003)

    Article  PubMed  CAS  Google Scholar 

  3. T. Mancini, B. Kola, F. Mantero, M. Boscaro, G. Arnaldi, High cardiovascular risk in patients with Cushing’s syndrome according to 1999 WHO/ISH guidelines. Clin. Endocrinol. (Oxf) 61, 768–777 (2004)

    Article  Google Scholar 

  4. R. Pivonello, A. Faggiano, G. Lombardi, A. Colao, The metabolic syndrome and the cardiovascular risk in Cushing’s syndrome. Endocrinol. Metab. Clin. North Am. 34, 327–339 (2005)

    Article  PubMed  CAS  Google Scholar 

  5. F. Fallo, N. Sonino, Should we evaluate for cardiovascular disease in patients with Cushing’s syndrome? Clin. Endocrinol. (Oxf) 71, 768–771 (2009)

    Article  Google Scholar 

  6. R.N. Clayton, D. Raskauskiene, R.C. Reulen, P.W. Jones, Mortality and morbidity in Cushing’s disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature. J. Clin. Endocrinol. Metab. 96, 632–642 (2011)

    Article  PubMed  CAS  Google Scholar 

  7. M.L. Muiesan, M. Lupia, M. Salvetti, C. Grigoletto, N. Sonino, M. Boscaro, E.A. Rosei, F. Mantero, F. Fallo, Left ventricular structural and functional characteristics in Cushing’s syndrome. J. Am. Coll. Cardiol. 41, 2275–2279 (2003)

    Article  PubMed  Google Scholar 

  8. A.M. Pereira, V. Delgado, J.A. Romijn, J.W. Smit, J.J. Bax, R.A. Feelders, Cardiac dysfunction is reversed upon successful treatment of Cushing’s syndrome. Eur. J. Endocrinol. 162, 331–340 (2010)

    Article  PubMed  CAS  Google Scholar 

  9. K.H. Yiu, N.A. Marsan, V. Delgado, N.R. Biermasz, E.R. Holman, J.W. Smit, R.A. Feelders, J.J. Bax, A.M. Pereira, Increased myocardial fibrosis and left ventricular dysfunction in Cushing’s syndrome. Eur. J. Endocrinol. 166, 27–34 (2012)

    Article  PubMed  CAS  Google Scholar 

  10. P.M. Toja, G. Branzi, F. Ciambellotti, P. Radaelli, M. De Martin, L.M. Lonati, M. Scacchi, G. Parati, F. Cavagnini, F.P. Giraldi, Clinical relevance of cardiac structure and function abnormalities in patients with Cushing’s syndrome before and after cure. Clin. Endocrinol. (Oxf) 76, 332–338 (2012)

    Article  CAS  Google Scholar 

  11. K.L. Gould, K. Lipscom, G.W. Hamilton, Physiologic basis for assessing critical coronary stenosis. Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. Am. J. Cardiol. 33, 87–94 (1974)

    Article  PubMed  CAS  Google Scholar 

  12. C. Caiati, C. Montaldo, N. Zedda, R. Montisci, M. Ruscazio, G. Lai, M. Cadeddu, L. Meloni, S. Iliceto, Validation of a new noninvasive method (contrast enhanced transthoracic second harmonic echo Doppler) for the evaluation of coronary flow reserve. Comparison with intracoronary Doppler flow wire. J. Am. Coll. Cardiol. 34, 1193–2000 (1999)

    Article  PubMed  CAS  Google Scholar 

  13. P.G. Camici, F. Crea, Coronary microvascular dysfunction. N. Eng. J. Med. 356, 830–840 (2007)

    Article  CAS  Google Scholar 

  14. T. Kiviniemi, Assessment of coronary blood flow and the reactivity of the microcirculation non-invasively with transthoracic echocardiography. Clin. Physiol. Funct. Imag. 28, 145–155 (2008)

    Article  Google Scholar 

  15. D. Rizzoni, C. Palombo, E. Porteri, M.L. Muiesan, M. Kozàkovà, G. La Canna, M. Nardi, D. Guelfi, M. Salvetti, C. Morizzo, F. Vittone, E.A. Rosei, Relationships between coronary flow vasodilator capacity and small artery remodelling in hypertensive patients. J. Hypertens. 21, 625–631 (2003)

    Article  PubMed  CAS  Google Scholar 

  16. M. Ragosta, H. Samady, R.B. Isaacs, L.W. Gimple, I.J. Sarembock, E.R. Powers, Coronary flow reserve abnormalities in patients with diabetes mellitus who have end-stage renal disease and normal epicardial coronary arteries. Am. Heart J. 147, 1017–1023 (2004)

    Article  PubMed  Google Scholar 

  17. M. Galderisi, G. de Simone, S. Cicala, M. Parisi, A. D’Errico, P. Innelli, M. de Divitiis, S. Mondillo, O. de Divitiis, Coronary flow reserve in hypertensive patients with hypercholesterolemia and without coronary heart disease. Am. J. Hypertens. 20, 177–183 (2007)

    Article  PubMed  Google Scholar 

  18. F. Fallo, A. Paoletta, F. Tona, M. Boscaro, N. Sonino, Response of hypertension to conventional antihypertensive treatment and/or steroidogenesis inhibitors in Cushing’s syndrome. J. Int. Med. 234, 595–598 (1993)

    Article  CAS  Google Scholar 

  19. P. Della Mea, M. Lupia, V. Bandolin, S. Guzzon, N. Sonino, R. Vettor, F. Fallo, Adiponectin, insulin resistance, and left ventricular structure in dipper and nondipper essential hypertensive patients. Am. J. Hypertens. 18, 30–35 (2005)

    Article  PubMed  CAS  Google Scholar 

  20. R.M. Lang, M. Bierig, R.B. Devereux, F.A. Flachskampf, E. Foster, P.A. Pellikka, M.H. Picard, M.J. Roman, J. Seward, J. Shanewise, S. Solomon, K.T. Spencer, M. St John Sutton, W. Stewart, American Society of Echocardiography’s Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology. Recommendations for chamber quantification. Eur. J. Echocardiogr. 7, 79–108 (2006)

    Google Scholar 

  21. G. de Simone, S.R. Daniels, R.B. Devereux, R.A. Meyer, M.J. Roman, O. de Divitiis, M.H. Alderman, Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and of the impact of overweight. J. Am. Coll. Cardiol. 19, 1550–1558 (1992)

    Article  PubMed  Google Scholar 

  22. F. Tona, A.L. Caforio, R. Montisci, A. Gambino, A. Angelini, M. Ruscazio, G. Toscano, G. Feltrin, A. Ramondo, G. Gerosa, S. Iliceto, Coronary flow velocity pattern and coronary flow reserve by contrast-enhanced transthoracic echocardiography predict long-term outcome in heart transplantation. Circulation 114(1 Suppl), I49–I55 (2006)

    PubMed  Google Scholar 

  23. R. Rubinshtein, E.H. Yang, C.S. Rihal, A. Prasad, R.J. Lennon, P.J. Best, L.O. Lerman, A. Lerman, Coronary microcirculatory vasodilator function in relation to risk factors among patients without obstructive coronary disease and low to intermediate Framingham score. Eur. Heart J. 31, 936–942 (2010)

    Article  PubMed  Google Scholar 

  24. W.G. Austen, J.E. Edwards, R.L. Frye, G.G. Gensini, V.L. Gott, L.S. Griffith, D.C. McGoon, M.L. Murphy, B.B. Roe, A reporting system on patients evaluated for coronary artery disease: report of the ad hoc committee for grading of coronary artery disease, Council on Cardiovascular Surgery, Dallas, TX: American Heart Association. Circulation 51, 5–40 (1975)

    Article  PubMed  CAS  Google Scholar 

  25. F. Rigo, L. Cortigiani, E. Pasanisi, M. Richieri, V. Cutaia, M. Celestre, A. Raviele, E. Picano, The additional prognostic value of coronary flow reserve on left anterior descending artery in patients with negative stress echo by wall motion criteria. A transthoracic vasodilator stress echocardiography study. Am. Heart J. 151, 124–130 (2006)

    Article  PubMed  Google Scholar 

  26. G.D. Smith, Y. Ben-Shlomo, A. Beswick, J. Yarnell, S. Lightman, P. Elwood, Cortisol, testosterone, and coronary heart disease: prospective evidence from the Caerphilly study. Circulation 112, 332–340 (2005)

    Article  PubMed  CAS  Google Scholar 

  27. J. Nijm, L. Jonasson, Inflammation and cortisol response in coronary artery disease. Ann. Med. 41, 224–233 (2009)

    Article  PubMed  CAS  Google Scholar 

  28. R. Fraser, M.C. Ingram, N.H. Andre, C. Morrison, E. Davies, J.M.C. Connell, Cortisol effects on body mass, blood pressure and cholesterol in the general population. Hypertension 33, 1364–1368 (1999)

    Article  PubMed  CAS  Google Scholar 

  29. B.R. Walker, S. Soderberg, B. Lindhal, T. Ollsson, Independent effects of obesity and cortisol in predicting cardiovascular risk factors in men and women. J. Intern. Med. 247, 198–204 (2000)

    Article  PubMed  CAS  Google Scholar 

  30. Y. Imai, K. Abe, S. Sasaki, N. Minami, M. Nihei, M. Munakata, O. Murakami, K. Matsue, H. Sekino, Y. Miura, K. Yoshinaga, Altered circadian blood pressure rhythm in patients with Cushing’s syndrome. Hypertension 12, 11–19 (1988)

    Article  PubMed  CAS  Google Scholar 

  31. F. Fallo, P. Maffei, A. Dalla Pozza, M. Carli, P. Della Mea, M. Lupia, F. Rabbia, N. Sonino, Cardiovascular autonomic function in Cushing’s syndrome. J. Endocrinol. Invest. 32, 41–44 (2009)

    PubMed  CAS  Google Scholar 

  32. T. Ohkubo, A. Hozawa, J. Yamaguchi, M. Kikuya, K. Ohmori, M. Michimata, M. Matsubara, J. Hashimoto, H. Hoshi, T. Araki, I. Tsuji, H. Satoh, S. Hisamichi, Y. Imai, Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J. Hypertens. 20, 2183–2189 (2002)

    Article  PubMed  CAS  Google Scholar 

  33. S. Schäfer, M. Kelm, S. Mingers, B.E. Strauer, Left ventricular remodeling impairs coronary flow reserve in hypertensive patients. J. Hypertens. 20, 1431–1437 (2002)

    Article  PubMed  Google Scholar 

  34. L. Kornel, W.A. Nelson, B. Manisundaram, R. Chigurupati, T. Hayashi, Mechanism of the effects of glucocorticoids and mineralocorticoids on vascular smooth muscle contractility. Steroids 58, 580–587 (1993)

    Article  PubMed  CAS  Google Scholar 

  35. H. Inoue, K. Humesono, T. Nishimori, Y. Hirata, T. Tanabe, Glucocorticoid-mediated suppression of the promoter activity of the cyclooxygenase-2 gene is modulated by expression of its receptor in vascular endothelial cells. Biochem. Biophys. Res. Commun. 254, 292–298 (1999)

    Article  PubMed  CAS  Google Scholar 

  36. I. Akaza, T. Yoshimoto, K. Tsuchiya, Y. Hirata, Endothelial dysfunction associated with hypercortisolism is reversible in Cushing’s syndrome. Endocr. J. 57, 245–552 (2010)

    Article  PubMed  Google Scholar 

  37. T.J. Anderson, A. Uehata, M.D. Gerhard, I.T. Meredith, S. Knab, D. Delagrange, E.H. Lieberman, P. Ganz, M.A. Creager, A.C. Yeung, A.P. Selwyn, Close relation of endothelial function in the human coronary and peripheral circulations. J. Am. Coll. Cardiol. 26, 1235–1241 (1995)

    Article  PubMed  CAS  Google Scholar 

  38. J.A. Whitworth, G.J. Mangos, J.J. Kelly, Cushing, cortisol, and cardiovascular disease. Hypertension 36, 912–916 (2000)

    Article  PubMed  CAS  Google Scholar 

  39. M. Rosenstock, S. Katz, A. Danon, Glucocorticoids regulate both phorbol ester and calcium ionophore-induced endothelial prostacyclin synthesis. Prostag. Leukotr. Ess. Fatty Acids 56, 1–8 (1997)

    Article  CAS  Google Scholar 

  40. S.S. Jun, Z. Chen, M.C. Pace, P.W. Shaul, Glucocorticoids downregulate cyclooxygenase-1 gene expression and prostacyclin synthesis in fetal pulmonary artery endothelium. Circ. Res. 84, 193–200 (1999)

    Article  PubMed  CAS  Google Scholar 

  41. K.M. Rogers, C.A. Bonar, J.L. Estrella, S. Yang, Inhibitory effect of glucocorticoid on coronary artery endothelial function. Am. J. Physiol. Heart Circ. Physiol. 283, H1922–H1928 (2002)

    PubMed  CAS  Google Scholar 

  42. S.L. Ong, J.A. Whitworth, How do glucocorticoids cause hypertension: role of nitric oxide deficiency, oxidative stress, and eicosanoids. Endocrinol. Metab. Clin. North Am. 40, 393–407 (2011)

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported. This research did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Francesco Fallo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fallo, F., Famoso, G., Capizzi, D. et al. Coronary microvascular function in patients with Cushing’s syndrome. Endocrine 43, 206–213 (2013). https://doi.org/10.1007/s12020-012-9764-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-012-9764-2

Keywords

Navigation